These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27718185)

  • 21. Determination of new immunoadjuvant saponin named QB-90, and analysis of its organ-specific distribution in Quillaja brasiliensis by HPLC.
    Fleck JD; de Costa F; Yendo AC; Segalin J; Dalla Costa TC; Fett-Neto AG; Gosmann G
    Nat Prod Res; 2013; 27(10):907-10. PubMed ID: 22404569
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Walkowicz WE; Fernández-Tejada A; George C; Corzana F; Jiménez-Barbero J; Ragupathi G; Tan DS; Gin DY
    Chem Sci; 2016 Mar; 7(3):2371-2380. PubMed ID: 27014435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural characterisation of new immunoadjuvant saponins from leaves and the first study of saponins from the bark of Quillaja brasiliensis by liquid chromatography electrospray ionisation ion trap mass spectrometry.
    Wallace F; Bennadji Z; Ferreira F; Olivaro C
    Phytochem Anal; 2019 Nov; 30(6):644-652. PubMed ID: 31059191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure of the saponin adjuvant QS-21 and its base-catalyzed isomerization product by 1H and natural abundance 13C NMR spectroscopy.
    Jacobsen NE; Fairbrother WJ; Kensil CR; Lim A; Wheeler DA; Powell MF
    Carbohydr Res; 1996 Jan; 280(1):1-14. PubMed ID: 8581890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Replacing the Rhamnose-Xylose Moiety of QS-21 with Simpler Terminal Disaccharide Units Attenuates Adjuvant Activity in Truncated Saponin Variants.
    Fuentes R; Ruiz-de-Angulo A; Sacristán N; Navo CD; Jiménez-Osés G; Anguita J; Fernández-Tejada A
    Chemistry; 2021 Mar; 27(14):4731-4737. PubMed ID: 33236801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploiting structure-activity relationships of QS-21 in the design and synthesis of streamlined saponin vaccine adjuvants.
    Ghirardello M; Ruiz-de-Angulo A; Sacristan N; Barriales D; Jiménez-Barbero J; Poveda A; Corzana F; Anguita J; Fernández-Tejada A
    Chem Commun (Camb); 2020 Jan; 56(5):719-722. PubMed ID: 31833496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100.
    Marciani DJ; Reynolds RC; Pathak AK; Finley-Woodman K; May RD
    Vaccine; 2003 Sep; 21(25-26):3961-71. PubMed ID: 12922132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quillaja saponin adjuvants: derivatives formed under sub-optimal conditions.
    Marciani DJ; Pathak AK; Reynolds RD
    Vaccine; 2002 Sep; 20(27-28):3237-8. PubMed ID: 12213391
    [No Abstract]   [Full Text] [Related]  

  • 29. IMXQB-80: A Quillaja brasiliensis saponin-based nanoadjuvant enhances Zika virus specific immune responses in mice.
    Cibulski S; Teixeira TF; Varela APM; de Lima MF; Casanova G; Nascimento YM; Fechine Tavares J; da Silva MS; Sesterheim P; Souza DO; Roehe PM; Silveira F
    Vaccine; 2021 Jan; 39(3):571-579. PubMed ID: 33339669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a novel saponin adjuvant derived from Quillaja saponaria on the immune response to recombinant hepatitis B surface antigen.
    So HS; Yoon HS; Choi DY; Kwon YS; Sung JH; Lee TG; Park ES; Cho HS; Lee BM; Cho JM; Ryu WS
    Mol Cells; 1997 Apr; 7(2):178-86. PubMed ID: 9163729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins.
    Tafaghodi M; Eskandari M; Kharazizadeh M; Khamesipour A; Jaafari MR
    Trop Biomed; 2010 Dec; 27(3):639-50. PubMed ID: 21399606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Syntheses and mucosal adjuvant activity of simplified oleanolic acid saponins possessing cinnamoyl ester.
    Shirahata T; Nagai T; Hirata N; Yokoyama M; Katsumi T; Konishi N; Nishino T; Makino K; Yamada H; Kaji E; Kiyohara H; Kobayashi Y
    Bioorg Med Chem; 2017 Mar; 25(6):1747-1755. PubMed ID: 28237555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and Evaluation of a QS-17/18-Based Vaccine Adjuvant.
    Wang P; Škalamera Đ; Sui X; Zhang P; Michalek SM
    J Med Chem; 2019 Feb; 62(3):1669-1676. PubMed ID: 30656932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of the trisaccharide portion of the immunologic adjuvant QS-21A via sulfonium-mediated oxidative and dehydrative glycosylation.
    Kim YJ; Gin DY
    Org Lett; 2001 Jun; 3(12):1801-4. PubMed ID: 11405715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of QS-21-xylose: establishment of the immunopotentiating activity of synthetic QS-21 adjuvant with a melanoma vaccine.
    Deng K; Adams MM; Damani P; Livingston PO; Ragupathi G; Gin DY
    Angew Chem Int Ed Engl; 2008; 47(34):6395-8. PubMed ID: 18624313
    [No Abstract]   [Full Text] [Related]  

  • 36. Preclinical evaluation of the synthetic adjuvant SQS-21 and its constituent isomeric saponins.
    Ragupathi G; Damani P; Deng K; Adams MM; Hang J; George C; Livingston PO; Gin DY
    Vaccine; 2010 Jun; 28(26):4260-7. PubMed ID: 20450868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elucidating the Mechanisms of Action of Saponin-Derived Adjuvants.
    Marciani DJ
    Trends Pharmacol Sci; 2018 Jun; 39(6):573-585. PubMed ID: 29655658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Saponin Interactions with Model Membrane Systems - Langmuir Monolayer Studies, Hemolysis and Formation of ISCOMs.
    de Groot C; Müller-Goymann CC
    Planta Med; 2016 Dec; 82(18):1496-1512. PubMed ID: 27760443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of C28 Oligosaccharide on Adjuvant Activity of QS-7 Analogues.
    Škalamera Đ; Kim H; Zhang P; Michalek SM; Wang P
    J Org Chem; 2020 Dec; 85(24):15837-15848. PubMed ID: 32463234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis.
    Oliveira-Freitas E; Casas CP; Borja-Cabrera GP; Santos FN; Nico D; Souza LO; Tinoco LW; da Silva BP; Palatnik M; Parente JP; Palatnik-de-Sousa CB
    Vaccine; 2006 May; 24(18):3909-20. PubMed ID: 16556475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.